Skip to main content

Economic Expertise in
  • Competition
  • Finance
  • HEOR, Epidemiology & Market Access
  • International Arbitration
Across Europe and Around the World

If you have a finance, economics or statistical challenge, we have the solution.

Our consultants and experts provide in-depth analyses of issues related to mergers and acquisitions, horizontal and vertical agreements, abuse of dominance, state aid, regulation compliance, and damage claims, including collective actions and high-profile cases.

We have significant experience managing large-scale, complex litigations across all areas of finance, including valuation, securities litigation, market manipulation, and insider trading. Our global teams are drawn from across our offices in Europe, North America, and Asia.

Our experts have deep knowledge and experience in health economics and outcomes research (HEOR) topics and methodologies. We can partner with clients to support pharmaceutical products throughout their life cycles, and our economic work ranges from cost-of-illness and cost-of-adverse-events calculations to sophisticated budget models.

We provide consulting and expert testimony on a variety of topics, including the economic evaluation of government regulations in some of the largest international arbitrations to date.

Cases & Publications

View All Insights

Veolia/Suez Merger Approval

On behalf of Suez in its acquisition by the international environmental services conglomerate Veolia, Analysis Group teams provided economic and financial analyses for review by regulatory agencies in multiple countries.

Read More

First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data

Journal of Clinical Oncology, 2024

Read More

Associated People

Yiqiao Xin
Yiqiao Xin

Is Data “The New Oil”? Non-Price Effects of Mergers in Data-Intensive Industries

In recent years, regulators and other interested parties have advocated for increased attention to non-price effects of mergers, particularly when data is a key input but not the main product of the merging parties.  

Read More

Associated People

Philipp Tillmann
Philipp Tillmann

Steinhoff International Holdings N.V. Shareholder Litigation

Following years of negotiation, Steinhoff International Holdings N.V., received approval from courts in the Netherlands and South Africa for a €1.7 billion global settlement with shareholders and creditors.

Read More

LVMH Moet Hennessy-Louis Vuitton SE Acquisition of Tiffany & Co.

For the proposed acquisition of global luxury jeweler Tiffany & Co. by LVMH Moët Hennessy Louis Vuitton SE (LVMH), an Analysis Group team led provided economic analysis in support of securing merger approval from competition authorities across nine countries and the European Union.

Read More

Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM

Future Oncology, 2024

Read More

Associated People

Mirko Fillbrunn
Mirko Fillbrunn

News & Events

  • Manager Mario Luca Explores How Mergers Impact Innovation in Concurrences
    Read More
  • Analysis Group Cohosts Panel on Risk and Loss Assessment in Emerging Economies at Paris Arbitration Week
    Read More
  • Principal Jessica Resch to Join Scenario Analysis Panel at GAR Live
    Read More
  • Principal Jessica Resch to Join Analysis Group/Signature Litigation Panel on Assessing Loss in Emerging Economies at Paris Arbitration Week
    Read More
  • Vice President Marianne Cunnington to Speak at Inaugural European Summit for Women Leaders in Life Sciences Law
    Read More
  • Analysis Group Researchers Support FDA BLA Approval of a Regenerative Medicine Product Using Novel External Benchmarking Statistical Method
    Read More
/